摘要
目的:探讨缬沙坦联合氨氯地平治疗社区老年原发高血压合并糖尿病疗效。方法:选取250例社区老年原发性高血压合并糖尿病患者为研究对象,随机分成观察组和对照组,对照组应用缬沙坦治疗,观察组采用氨氯地平联合缬沙坦治疗,对比两组患者的治疗效果。结果:经治疗后,观察组患者SBP(收缩压)、DBP(舒张压)显著低于对照组(P<0.05),FPG(空腹血糖)、2hPG(餐后2h血糖)、HbAlc(糖化血红蛋白)均显著低于对照组P<0.05)。在不良反应发生率显著低于对照(P<0.05)。结论:氨氯地平片与缬沙坦胶囊联合用于社区老年原发性高血压合并糖尿病的治疗中,可显著改善患者血压及血糖水平,不良反应较少,值得推广应用。
Objective:Valsartan Amlodipine therapeutic community elderly primary hypertension and dia-betes treatment.Methods:250 cases of community elderly hypertensive patients with diabetes mellitus for the study were randomly divided into observation group and control group,the control group received valsartan treatment,observation group Amlodipine valsartan,compared two groups patient outcomes.Results:After treatment,the observation group were SBP (SBP),DBP (diastolic)was significantly lower than the control group (P <0.05),FPG (fasting plasma glucose),2hPG (2h postprandial blood glucose),HbAlc (glycated hemoglobin)They were significantly lower than the control group,P <0.05 ).The incidence of adverse e-vents was significantly lower than the control (P <0.05).Conclusion:Valsartan Amlodipine tablets and cap-sules in combination to treat elderly patients with primary hypertension and diabetes community in,can sig-nificantly improve patients'blood pressure and blood sugar levels,fewer adverse reactions,should be widely applied.
出处
《数理医药学杂志》
2015年第12期1776-1777,共2页
Journal of Mathematical Medicine
